Borman Mark P 4
4 · U.S. Stem Cell, Inc. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Borman Mark P
Director
Transactions
- Award
Stock Option (right to buy)
2019-11-18+1,500,000→ 6,002,810 totalExercise: $0.00From: 2019-11-18Exp: 2029-11-18→ Common Stock (1,500,000 underlying)
Holdings
- 526,942(indirect: By Trust)
Common Stock